Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00066937 · ClinicalTrials.gov registry record · Phase 2
Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT00066937: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT00066937 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00066937, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the combination of cognitive-behavioral treatment and nortriptyline are more effective than each treatment alone in reducing the pain and disability associated with TMD.
Interventions
- BEHAVIORAL CBT
- DRUG Nortriptyline Oral Capsule
- DRUG Benztropine Oral Product
- BEHAVIORAL Disease MGT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2002-11 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00066937
The ClinicalTrials.gov registry entry for NCT00066937 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which CBT is the first listed.
NCT00066937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00066937 about?
NCT00066937 is a clinical study titled "Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)". The purpose of this study is to determine whether the combination of cognitive-behavioral treatment and nortriptyline are more effective than each treatment alone in reducing the pain and disability associated with TMD.
What is the current status of trial NCT00066937?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2002-11. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00066937?
The interventions under investigation include: CBT (BEHAVIORAL), Nortriptyline Oral Capsule (DRUG), Benztropine Oral Product (DRUG), Disease MGT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00066937?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.